Epilepsy in Patients With Primary CNS Lymphoma
Epilepsy affects a quarter of patients with PCNSL, with half experiencing it at the time of initial presentation and potentially serving as a marker of disease progression. Further research is necessary to assess the broader applicability of these findings because they are subject to the constraints of a retrospective design and tertiary center setting.
Authors
- Khê Hoang‐Xuan (ORCID: https://orcid.org/0000-0003-4072-1999)
- Sylvain Choquet (ORCID: https://orcid.org/0000-0002-7791-0470)
- Oumaima Aboubakr (ORCID: https://orcid.org/0000-0002-7280-6201)
- Laura Rozenblum (ORCID: https://orcid.org/0000-0002-6306-8008)
- Magali Le Garff‐Tavernier (ORCID: https://orcid.org/0000-0002-3131-3240)
- Agustí Alentorn (ORCID: https://orcid.org/0000-0002-7220-2686)
- Lucia Nichelli (ORCID: https://orcid.org/0009-0006-0934-5365)
- Bertrand Mathon (ORCID: https://orcid.org/0000-0002-9182-5846)
- Karima Mokhtari (ORCID: https://orcid.org/0000-0002-4777-7584)
- Delphine Leclercq (ORCID: https://orcid.org/0000-0003-1110-3833)
- Caroline Houillier (ORCID: https://orcid.org/0000-0003-2931-7522)
- Sophie Dupont (ORCID: https://orcid.org/0000-0001-6516-4688)
- Aurélie Kas (ORCID: https://orcid.org/0000-0001-9463-3658)
- Alexandre Carpentier
Institutions
- Centre National de la Recherche Scientifique (FR)
- Inserm (FR)
- Sorbonne Université (FR)
- Neurology, Inc (US)
- NeurON : Interface Neuro-machine
Publication Details
- Journal
- Neurology
- Published
- 2024-08-08
- DOI
- https://doi.org/10.1212/wnl.0000000000209748
- Citations
- 4
- Primary Topic
- CNS Lymphoma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.48